By the mid '90s, transcatheter ablation of atrial fibrillation (AF) has undergone a strong and impetuous advance, becoming a well known and worldwide accepted therapeutic procedure offered to patients with different types of AF and clinical features. The present paper aims to describe the main concepts behind the evolution of transcatheter ablation of AF, to review clinical indications, and to analyze current outcomes in terms of efficacy and safety.